The course of adverse effects of nortriptyline and venlafaxine in elderly patients with major depression.
Kok
Rob M
RM
Department of Old Age Psychiatry, Parnassia Psychiatric Institute, the Hague, the Netherlands.
Aartsen
Marja
M
Nolen
Willem A
WA
Heeren
T
T
D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects* / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects* / Q000627:therapeutic use; D015897:Comorbidity; D003430:Cross-Sectional Studies; D003511:Cyclohexanols / Q000009:adverse effects* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D005260:Female; D005500:Follow-Up Studies; D006778:Hospitals, Psychiatric; D006801:Humans; D008297:Male; D008875:Middle Aged; D009426:Netherlands; D009661:Nortriptyline / Q000009:adverse effects* / Q000627:therapeutic use; D010552:Personality Assessment; D012307:Risk Factors; D000069470:Venlafaxine Hydrochloride
D018687:Antidepressive Agents, Second-Generation; D000929:Antidepressive Agents, Tricyclic; D003511:Cyclohexanols; D000069470:Venlafaxine Hydrochloride; D009661:Nortriptyline